LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30143% above fair value
$14.15−0.22 (-1.53%)
Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –
LifeStance Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
LifeStance Health's enterprise value was $5.54B on Nov 11, 2026, against $2.61B a year earlier. Over the last 5 years it ranged from $1.70B to $5.54B, with a median of $2.81B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.54B | +96.6% |
| 2025 | Dec 31, 2025 | $2.82B | -6.1% |
| 2024 | Dec 31, 2024 | $3.00B | -5.5% |
| 2023 | Dec 29, 2023 | $3.17B | +60.1% |
| 2022 | Dec 30, 2022 | $1.98B | -43.5% |
| 2021 | Dec 31, 2021 | $3.51B | – |
See a number that looks wrong?